Assay of myo-inositol in cerebrospinal fluid and plasma by chemical ionization mass spectrometry of the hexaacetate derivative.
The paper describes a capillary gas chromatographic/mass spectrometric technique to quantitate myo-inositol in cerebrospinal fluid (CSF) and plasma. A highly abundant fragment ion, m/z 373, for the hexaacetate derivative of myo-inositol was generated by chemical ionization (CI). This ion and the analogous ion of hexadeuterated myo-inositol (the internal standard), m/z 379, were both monitored in the assay. CI was performed with acetonitrile vapor in an ion trap mass spectrometer. Microliter quantities of CSF or plasma were mixed with the internal standard, dried and acetylated. After a post-derivatization clean-up, samples were analyzed on a capillary gas chromatograph interfaced with a Finnigan ion trap. Standard curves constructed for both CSF and plasma were linear and reproducible. Absence of matrix effects and good precision in the results indicate the suitability of the technique for critical assays. Results from the determination of myo-inositol in the CSF and plasma of healthy subjects and those with neurological deficits are reported.
Shetty
H U
HU
Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, Bethesda, Maryland 20892.
Holloway
H W
HW
D000107:Acetylation; D004314:Down Syndrome / Q000097:blood / Q000134:cerebrospinal fluid; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007294:Inositol / Q000031:analogs & derivatives* / Q000032:analysis* / Q000097:blood / Q000134:cerebrospinal fluid; D008875:Middle Aged; D012016:Reference Values
C067741:1,2,3,4,5,6-hexa-O-acetyl-myo-inositol; D007294:Inositol